preliminary recommendation for the non-inclusion of eribulin in the treatment of soft tissue sarcoma in the PNF
[DEPARTMENT CIRCULAR NO. 2022- 2048] Creation of a Screening Committee for the Appointment of Health Technology Assessment Committee (HTAC) Members
[DEPARTMENT CIRCULAR NO. 2022- 0288] Nomination to the Health Technology Assessment Council (HTAC) Social Anthropologist Core Committee Member
[DEPARTMENT CIRCULAR NO. 2022- 0291] Health Technology Assessment Council (HTAC) Recommendation to include Potassium Citrate 15 mEq Extended Release (ER) Tablet in the Philippine National Formulary
[DEPARTMENT CIRCULAR NO. 2022- 0289] Health Technology Assessment Council (HTAC) Recommendation to include Tocilizumab in the Philippine National Formulary
[DEPARTMENT CIRCULAR NO. 2022- 0257] Changes to the Topic Nomination and Appeals Processes of the Philippine HTA Process Guide
[DEPARTMENT PERSONNEL ORDER NO. 2022- 2780 – A] Amendment to the Department Personnel Order No. 2021-2780 entitled “Creation of the pool of clinical experts for consultation on the evaluation of assessment topics” to include Expert Advisory Committee as additional experts
[DEPARTMENT PERSONNEL ORDER NO. 2022- 1245] Appointment of the New Member of the Health Technology Assessment Council Subcommittee on Drugs
preliminary recommendation for the inclusion of Potassium Citrate 1620 mg (15 mEq) tablet in the PNF.
